In vivo, transgenic miceexpressing porcine TRPC1 (Tg-pTRPC1) on a HFD were used as obesity models to explore the potential effect of TRPC1 on fat deposition, hepatic steatosis, glucose metabolism, and insulin sensitivity. This evidence concerns the gene TRPC1 and fatty liver disease.